Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Chronic liver injury characteristically results in hepatic inflammation, which represents a prerequisite for organ fibrosis. Although NKT cells are abundantly present in liver and involved in hepatic inflammation, molecular mechanisms of their recruitment in liver fibrosis remained elusive. We hypothesized that chemokine receptor CXCR6 and its ligand CXCL16 control NKT cell migration and functionality in liver fibrosis. In patients with chronic liver diseases (n = 58), CXCR6 and CXCL16 expression was intrahepatically upregulated compared with controls. In murine liver, Cxcl16 was strongly expressed by endothelium and macrophages, whereas lymphocyte populations (NKT, NK, CD4 T, CD8 T cells) expressed CXCR6. Intravital two-photon microscopy imaging of Cxcr6+/gfp and Cxcr6gfp/gfp mice and chemotaxis studies in vitro revealed that CXCR6 specifically controls hepatic NKT cell accumulation during the early response upon experimental liver damage. Hepatic invariant NKT cells expressed distinct proinflammatory cytokines including IFN-γ and IL-4 upon injury. CXCR6-deficient mice were protected from liver fibrosis progression in two independent experimental models. Macrophage infiltration and protein levels of inflammatory cytokines IFN-γ, TNF-α, and IL-4 were also reduced in fibrotic livers of Cxcr6−/− mice, corroborating that hepatic NKT cells provide essential cytokine signals perpetuating hepatic inflammation and fibrogenesis. Adoptive transfer of NKT cells, but not CD4 T cells, isolated from wild type livers restored hepatic fibrosis in Cxcr6−/− mice upon experimental steatohepatitis. Our results demonstrate that hepatic NKT cells accumulate CXCR6-dependent early upon injury, thereby accentuating the inflammatory response in the liver and promoting hepatic fibrogenesis. Interfering with CXCR6/CXCL16 might therefore bear therapeutic potential in liver fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this model, fibrosis amelioration appeared to depend on effects on NK-cells rather than direct modulation of macrophages, although macrophage phenotypes were not extensively characterized.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [87]
In the citing paper
“A similar protective effect was observed in a MASH model, supporting the relevance of intercellular crosstalk in shaping macrophage function.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [87]
In the citing paper
“C-X-C chemokine receptor 6 (CXCR6) is mainly expressed in natural killer (NK) cells, whereas its ligand CXCL16 is expressed in macrophages and endothelial cells, and both are also upregulated in patients with chronic liver disease.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [87]
In the citing paper
“Mechanistically, several ligand-receptor pairs mediate the effects of NKT cells, including LIGHT-HVEM (which promotes hepatocyte steatosis) and CXCL16-CXCR6 (which promotes hepatic NKT cell recruitment and liver fibrosis).93,94”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [94]
In the citing paper
“NKT cells are much more abundant in mouse livers than in humans, and they promote NASH, fibrosis and carcinogenesis in experimental models.86,96,97”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [97]
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
McDonald, B., Pittman, K., Menezes, G. B., Hirota, S. A., Slaba, I., Waterhouse, C. C. M., Beck, P. L., Muruve, D. A., & Kubes, P. (2010) · Science · doi:10.1126/science.1195491 · Cited by 1,210 · cited 1×
“have applied this method for liver in living mice, mostly because of artifacts created by breath movements and the autofluorescence of hepatic tissue (27, 30).”
MethodGodfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J., & Kaer, L. V. (2004) · Nature Reviews Immunology · doi:10.1038/nri1309 · Cited by 1,182 · cited 6×
“ferent types of proinflammatory cytokines, including IL-4, IFN-g, and TNF-a (14).”
BackgroundInfluentialTracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.-R., Koezuka, Y., & Kronenberg, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.741 · Cited by 887 · cited 1×
“Ab or a-GalCer (17), resulting in low hepatic NKT cell numbers in chronic injury, such as fibrosis (12).”
BackgroundKarlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782 · cited 2×
“Hepatocytes were isolated from murine livers by conventional collagenase perfusion methodology (6).”
BackgroundMethodSelf-citationIntravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids
Geissmann, F., Cameron, T. O., Sidobre, S., Manlongat, N., Kronenberg, M., Briskin, M. J., Dustin, M. L., & Littman, D. R. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030113 · Cited by 680 · cited 7×
“(15) and in macrophages or dendritic cells of other organs (22).”
BackgroundResultInfluentialBaeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609 · cited 4×
“Biochemical assays and gene and protein expression studies were performed as described previously (8, 24, 25).”
MethodInfluentialSelf-citation
Cited by
Items 101–200 of 268
Chatzigeorgiou, A., & Chavakis, T. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_8 · Cited by 48
“CXCR6-dependent NKT cell accumulation to the liver takes place early during the development of NASH (Wehr et al. 2013).”
BackgroundThe Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer
Gibert-Ramos, A., Sanfeliu-Redondo, D., Aristu-Zabalza, P., Martínez-Alcocer, A., Gracia-Sancho, J., Guixé-Muntet, S., & Fernández-Iglesias, A. (2021) · Cancers · doi:10.3390/cancers13225719 · Cited by 41
Visualizing liver anatomy, physiology and pharmacology using multiphoton microscopy
Wang, H., Liang, X., Gravot, G., Thorling, C. A., Crawford, D. H., Xu, Z. P., Liu, X., & Roberts, M. S. (2016) · Journal of Biophotonics · doi:10.1002/jbio.201600083 · Cited by 44
CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction
Li, T., Pan, J., Chen, H., Fang, Y., & Sun, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.012 · Cited by 41
GARP on hepatic stellate cells is essential for the development of liver fibrosis
Zhang, X., Sharma, P., Maschmeyer, P., Hu, Y., Lou, M., Kim, J., Fujii, H., Unutmaz, D., Schwabe, R. F., & Winau, F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.05.043 · Cited by 43
Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
Liedtke, C., Nevzorova, Y. A., Luedde, T., Zimmermann, H., Kroy, D., Strnad, P., Berres, M.-L., Bernhagen, J., Tacke, F., Nattermann, J., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.814496 · Cited by 37
“Moreover, reduced NK T-cell accumulation in Cxcr6 mice led to the diminished presence of the pro-inflammatory cytokines IFN-γ, TNF-α, and IL-4 in the hepatic microenvironment, and overall reduced fibrogenesis (111).”
BackgroundSelf-citationTargeted delivery strategies: The interactions and applications of nanoparticles in liver diseases
Meng, X., Zhu, G., Yang, Y., & Sun, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116702 · Cited by 41
Cell Mediators of Autoimmune Hepatitis and Their Therapeutic Implications
Montaño‐Loza, A. J., & Czaja, A. J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3473-z · Cited by 38
“Each cell population has inhibitory (-) and stimulatory (?) actions mediated by the secretion of proinflammatory (IFN-c, TNF-a, IL-2, IL-4, IL-17, IL-21) and antiinflammatory (IL-22, IL-10) cytokines depending on the cell type.”
BackgroundInfluentialLiu, B., Jiang, J., Liang, H., Xiao, P., Lai, X., Nie, J., Yu, W., Gao, Y., & Wen, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107907 · Cited by 40
Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
Fu, Y., Zhou, Y., Shen, L., Li, X., Zhang, H., Cui, Y., Zhang, K., Li, W., Chen, W., Zhao, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.973366 · Cited by 40
“, 2015), inflammatory lymphocytes (Wehr et al., 2013), angiogenesis (Ehling et al.”
BackgroundFunction and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease
Chen, W., Zhang, J., Fan, H., & Zhu, J. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818815184 · Cited by 37
Cell therapy in end-stage liver disease: replace and remodel
Hu, X.-H., Chen, L., Wu, H., Tang, Y.-B., Zheng, Q.-M., Wei, X.-Y., Wei, Q., Huang, Q., Chen, J., & Xu, X. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03370-z · Cited by 32
Liver sinusoidal endothelial cells as potential drivers of liver fibrosis (Review)
Gao, J.-Q., Zuo, B., & He, Y. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13164 · Cited by 41
“In addition, chemokine receptor CXCR6 on LSECs and its ligand CXCL16 on natural killer T cells (NKTs) control NKT cell migration (69).”
BackgroundThe DRF motif of CXCR6 as chemokine receptor adaptation to adhesion
Koenen, A., Babendreyer, A., Schumacher, J., Pasqualon, T., Schwarz, N., Seifert, A., Deupí, X., Ludwig, A., & Yildiz, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173486 · Cited by 37
Self-citationInnate immunity and early liver inflammation
Zhou, J. Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175147 · Cited by 40
“CXCR6 was identified as a receptor to regulate mouse intrahepatic NKT cell frequencies and its ligand CXCL16 is overexpressed in macrophages and endothelium near injury areas (10).”
BackgroundZeißig, S., Peuker, K., Iyer, S., Gensollen, T., Dougan, S. K., Olszak, T., Kaser, A., & Blumberg, R. S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701428114 · Cited by 33
Fibrotic Response to Biomaterials and all Associated Sequence of Fibrosis
Jones, K. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800196-7.00009-8 · Cited by 42
Zhu, H., Zhang, Q., & Chen, G. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.021 · Cited by 33
Innate-like T cells in liver disease
Yang, A. Y.-P., Wistuba‐Hamprecht, K., Greten, T. F., & Ruf, B. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.05.008 · Cited by 40
Mathä, L., Romera‐Hernández, M., Steer, C. A., Yin, Y. H., Orangi, M., Shim, H. B., Chang, C.-K., Rossi, F. M. V., & Takei, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.679509 · Cited by 35
“In naïve mice, CXCR6, which is required for some lymphocytes to enter the liver (43), was highly expressed on ~25% of lung ILC2s, ~50% of PB ILC2s and ~70%of liver ILC2s.”
BackgroundConstitutively Active Chemokine CXC Receptors
Han, X. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-417197-8.00009-2 · Cited by 34
Yeung, S. S.-H., Ho, J. Y. S., & Chang, R. C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00660-5 · Cited by 36
Vachliotis, I. D., & Pοlyzos, S. A. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00657-5 · Cited by 33
“…IL-6 was higher in obese circulating and hepatic CXCL16 was reportedly increased in NAFLD patients [166]; furthermore, CXCR6 + NKT cells [167] and autoaggresive CXCR6 + CD8 + T cells [168] (CXCR6 is the receptor of CXCL16) have been identified in the liver of MCD diet-fed mice and…”
Mechanisms of liver fibrosis in metabolic syndrome
Mehal, W. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100015 · Cited by 28
“79 80 Collectively, therefore, there are strong data for NK-T cells having a role in steatosis and hepatocyte injury in NASH, and data for NK-T cells having a role in liver fibrosis in other mechanism, suggesting that will also have a role in NASH mediated fibrosis.”
BackgroundLi, Z., Gu, M., Zaparte, A., Fu, X., Mahen, K. K., Mrdjen, M., Li, X. S., Yang, Z., Ma, J., Thoudam, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55084-2 · Cited by 40
Baeck, C., & Tacke, F. (2014) · EXCLI journal · doi:10.17877/de290r-15572 · Cited by 37
“HSCs, known for vitamin A storage and collagen synthesis in liver-fibrosis (as activated myofibroblasts), have been suggested as cells with antigen-presenting capacity itself that can activate T cell responses, e.g. after bacterial challenge (Winau et al., 2007; Nevzorova et al., 2012) The liver is also one of the ric…”
BackgroundInfluentialSelf-citationThe Role of Chemokines in Hepatitis C Virus-Mediated Liver Disease
Braß, A., & Brenndörfer, E. D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034747 · Cited by 33
Heymann, F., Niemietz, P. M., Peusquens, J., Ergen, C., Kohlhepp, M. S., Mossanen, J. C., Schneider, C., Vogt, M., Tolba, R. H., Trautwein, C., et al. (2015) · Journal of Visualized Experiments · doi:10.3791/52607 · Cited by 34
Self-citationMyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs
Ge, S., Yang, W. P., Chen, H., Yuan, Q., Liu, S., Zhao, Y., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212413 · Cited by 29
“Hepatic macrophages interact with other immune cells; for instance, they secrete the chemokine CXCL16 that attracts NKT cells, which in turn can activate pro-inflammatory signals in macrophages [38].”
BackgroundLiu, J., Ding, M., Bai, J., Luo, R., Liu, R., Qu, J., & Li, X. (2023) · iMeta · doi:10.1002/imt2.76 · Cited by 25
“Besides, it was found that CXCR6 promoted iNKT migration in the liver and the release of proinflammatory factors IFN ‐ γ and IL ‐ 4 from iNKT cells, which further resulted in macrophage infiltration and hepatic inflammation in the livers of MCD diet ‐ treated mice [151].”
BackgroundMAIT cells: programmed in the thymus to mediate immunity within tissues
Lantz, O. J., & Legoux, F. P. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.04.016 · Cited by 26
Ho, C.-H., Huang, J.-H., Sun, M.-S., Tzeng, I., Hsu, Y., & Kuo, C. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6671129 · Cited by 31
Qin, M., Guo, Y., Jiang, L., & Wang, X. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2741-9 · Cited by 26
Felli, É., Nulan, Y., Ortega‐Ribera, M., Fernández‐Iglesias, A., & Gracia‐Sancho, J. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.10.017 · Cited by 39
Chung, S., Lee, C. M., & Zhang, M. (2022) · Nanoscale Horizons · doi:10.1039/d2nh00289b · Cited by 32
Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies
Jia, F., Hu, X., Kimura, T., & Tanaka, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910303 · Cited by 27
Wang, H., Shao, Y., Zhang, S., Xie, A., Ye, Y., Shi, L., Jin, L., Pan, X., Lin, Z., Li, X., et al. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx040 · Cited by 26
Langeneckert, A. E., Lunemann, S., Martrus, G., Salzberger, W., Hess, L. U., Ziegler, A. E., Poch, T., Ravichandran, G., Matschl, U., Bosse, J. B., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201847965 · Cited by 26
Jiang, L., Yang, M., Li, X., Wang, Y., Zhou, G., & Zhao, J. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00762 · Cited by 22
Live Imaging of Innate and Adaptive Immune Responses in the Liver
Li, L., & Zeng, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.564768 · Cited by 28
“Instead, this chemokine signaling functioned to maintain the survival of hepatic iNKT cells (60) and to attract circulating iNKT cells into the inflamed liver during injury (61) and cancer (62).”
BackgroundWang, H., Li, L., Li, Y., Li, Y., Sha, Y., Wen, S., You, Q., Liu, L., Shi, M., & Zhou, H. (2020) · Theranostics · doi:10.7150/thno.51369 · Cited by 26
“As previously reported, NK and NKT cells secrete IFN-γ to induce the apoptosis of activated HSCs, thereby exerting anti-fibrotic effects [80-83].”
BackgroundInteraction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review)
Cheng, Q.-N., Yang, X. Y., Wu, J., Ai, W., & Ni, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12003 · Cited by 24
Wei, X., Qian, J., Yao, W., Chen, L., Guan, H., Chen, Y., Xie, Y., Lu, H., Zhang, Z., Shi, L., et al. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12775 · Cited by 25
Resident Immune Cells of the Liver in the Tumor Microenvironment
Lu, Y., Ma, S., Ding, W., Sun, P., Zhou, Q., Duan, Y., & Sartorius, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.931995 · Cited by 25
“Liver sinusoidal endothelial cells (LSECs) and KCs can secrete CXCL6 that promotes the homing of CXCR6 NKT cells (50, 51).”
BackgroundMa, K. L., Wu, Y., Zhang, Y., Wang, G. H., Hu, Z. B., & Ruan, X. Z. (2018) · Europe PMC (PubMed Central) · Cited by 25
Wu, C., Cheng, D., Peng, Y., Li, Y., Fu, C., Wang, Y. X., Fu, L., Peng, S., & Ni, X. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.683506 · Cited by 24
“Notably, a number of previous studies have shown that the CXCL6 level is increased in the sera of patients with liver fibrosis and its expression is increased in the liver tissues of patients with liver fibrosis (19, 52, 53).”
BackgroundThe Biological Function of Kupffer Cells in Liver Disease
Ma, Y., Yang, M., He, Z., Wei, Q., & Li, J. (2017) · InTech eBooks · doi:10.5772/67673 · Cited by 25
Lunemann, S., Langeneckert, A. E., Martrus, G., Hess, L. U., Salzberger, W., Ziegler, A. E., Löbl, S. M., Poch, T., Ravichandran, G., Sauter, J., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ma1118-428r · Cited by 23
The Role of Chemokine Receptors in Renal Fibrosis
Wu, F., Sun, C. C., & Jianquan, L. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_21 · Cited by 23
CXCR6 protects from inflammation and fibrosis in NEMOLPC-KO mice
Liepelt, A., Wehr, A., Kohlhepp, M. S., Mossanen, J. C., Kreggenwinkel, K., Denecke, B., Costa, I. G., Luedde, T., Trautwein, C., & Tacke, F. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.020 · Cited by 19
Self-citationQian, Y., Shang, Z., Gao, Y., Wu, H., & Kong, X. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.014 · Cited by 22
Zhong, X., Lv, M., Ma, M., Huang, Q., Hu, R., Li, J., Yi, J., Sun, J., & Zhou, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115131 · Cited by 22
Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence
Liu, Z., Xiang, H., Xiang, D., Xiao, S., Xiang, H., Xiao, J., Ren, H., Hu, P., Liu, H., & Peng, M. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00579-7 · Cited by 22
“CXCL16 is produced by macrophages, which is a survival and maturation factor for hepatic NKT cells, resulting in an accumulation of NKT cells at sites of injury [42].”
BackgroundSagami, S., Ueno, Y., Tanaka, S., Fujita, A., Niitsu, H., Hayashi, R., Hyogo, H., Hinoi, T., Kitadai, Y., & Chayama, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169681 · Cited by 18
Cui, Y., Wu, H., Liu, Z., Ma, T., Liang, W., Zeng, Q., Chen, D., Qin, Q., Huang, B., Wang, M. H., et al. (2022) · The Journal of Pathology · doi:10.1002/path.6031 · Cited by 17
Type 1 invariant natural killer T cells in chronic inflammation and tissue fibrosis
Kumar, V., Hertz, M., Agro, A., & Byrne, A. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1260503 · Cited by 23
Cui, G., Abe, S., Kato, R., & Ikuta, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1349184 · Cited by 23
Wang, J., Su, F., Wang, S., Lu, X.-C., Zhang, S.-H., Chen, D., Chen, N., & Zhong, J.-Q. (2014) · PubMed Central · Cited by 21
Nanomaterial Manipulation of Immune Microenvironment in the Diseased Liver
Hu, M., & Huang, L. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201805760 · Cited by 18
Extrahepatic factors in hepatic immune regulation
Zhang, S., Lu, S., & Li, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941721 · Cited by 18
“The initiative inflammatory activation of HSCs and KCs results in the chemokine-mediated infi ltration of monocytes (35), neutrophils (36), NK and NKT cells (37).”
BackgroundInnate immune cells link dietary cues to normal and abnormal metabolic regulation
Zhang, P., Watari, K., & Karin, M. (2025) · Nature Immunology · doi:10.1038/s41590-024-02037-y · Cited by 19
“Moreover, Kupffer cell/macrophage-derived CXCL16 facilitates the accumulation of liver NKT cells, which also contribute to liver inflammation and fibrosis 203 .”
Liver-Resident Memory CD8+ T Cells: Possible Roles in Chronic HBV Infection
Han, J. W., & Shin, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010283 · Cited by 19
Therapeutic Potential of G Protein‐Coupled Receptors Against Nonalcoholic Steatohepatitis
Sun, D., Yang, X., Wu, B., Zhang, X., Li, H., & She, Z. (2021) · Hepatology · doi:10.1002/hep.31852 · Cited by 17
Wu, Y.-B., An, C., Jin, X., Hu, Z., & Wang, Y. (2020) · Scientific Reports · doi:10.1038/s41598-019-56933-7 · Cited by 18
The role of the CXCR6/CXCL16 axis in the pathogenesis of fibrotic disease
Wang, F., Wu, T.-Q., Lin, Y., Jiao, Y.-R., Li, J., Ruan, Y., Yin, L., & Chen, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112015 · Cited by 17
Crosstalk in extrahepatic and hepatic system in NAFLD / NASH
Duan, Y., Yang, Y. Z., Zhao, S., Bai, Y., Yao, W., Gao, X., & Yin, J. (2024) · Liver International · doi:10.1111/liv.15967 · Cited by 17
“133,134 B cells, comprising a substantial portion of intrahepatic lymphocytes, also impact liver fibrosis.”
Molecular response of liver sinusoidal endothelial cells on hydrogels
Bartneck, M., Topuz, F., Tag, C. G., Sauer-Lehnen, S., Warzecha, K. T., Trautwein, C., Weiskirchen, R., & Tacke, F. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.02.045 · Cited by 17
Self-citationIncorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease
Czaja, A. J. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i25.3705 · Cited by 17
Uvarova, A. N., Stasevich, E. M., Ustiugova, A. S., Mitkin, N. A., Zheremyan, E. A., Sheetikov, S. A., Zornikova, K. V., Васильевна, Б. А., Rubtsov, M. A., Kulakovskiy, I. V., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813790 · Cited by 15
“Likewise, CXCR6 may be involved in tumor progression [11] and participate in the recruitment of immune cells to non-lymphoid organs during chronic inflammation [12,13] and acute respiratory diseases [14,15].”
BackgroundLipid nanoparticle formulations for targeting leukocytes with therapeutic RNA in liver fibrosis
Bartneck, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.009 · Cited by 15
Moon, J., Jeon, J., Kong, E., Hong, S., Lee, J., Lee, E. K., & Kim, P. (2021) · Biomedical Optics Express · doi:10.1364/boe.442608 · Cited by 14
Yang, M. J., Khoukaz, L., Qi, X., Kimchi, E. T., Staveley-O’Carroll, K. F., & Li, G. (2021) · Biomedicines · doi:10.3390/biomedicines9121893 · Cited by 18
Bi, H., Liu, Z., & Cui, Y. R. (2015) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2015.01.002 · Cited by 15
“NKT cell subsets with different functions exist in humans and mice, including classical (type I) invariant and other CD1d-dependent (type II) NKT cells, and also CD1d-independent (NKT-like) T cells.(23) NKT cells”
BackgroundInnate-like T lymphocytes in chronic liver disease
Papanastasatou, M., & Verykokakis, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1114605 · Cited by 15
“Infiltration of MAIT cells in HCC is reduced due to the lower expression of the chemokine receptors, CXCR6, CCR6, and CCR9 (117).”
BackgroundInfluentialIs there a role for adaptive immunity in nonalcoholic steatohepatitis?
Sutti, S., Jindal, A., Bruzzì, S., Locatelli, I., Bozzola, C., & Albano, E. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i13.1725 · Cited by 16
Chen, S., Lv, T., Sun, G., Li, S., Duan, W., Zhang, C., Jin, H., Tian, D., Li, M., Shan, S., et al. (2022) · Hepatology International · doi:10.1007/s12072-021-10267-7 · Cited by 15
Wang, L., Huang, Y., Chen, J., Gao, J., Chen, S., Zhao, M., Lin, J., Zhou, S., Shen, Y., & Cheng, Y. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1635763 · Cited by 26
Lan, Y., Ng, C.-T., Ong, C. N., Yu, L. E., & Bay, B. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111702 · Cited by 11
The role of unconventional T cells in maintaining tissue homeostasis
LeBlanc, G., Kreissl, F. K., Melamed, J., Sobel, A. L., & Constantinides, M. G. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101656 · Cited by 17
Lipid metabolism in the immune niche of tumor-prone liver microenvironment
Chen, J., Chan, T. T.-H., & Zhou, J. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad081 · Cited by 13
Feng, J., Song, H., Province, M. A., Li, G., Payne, P., Chen, Y., & Li, F. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1369242 · Cited by 14
Novel Targets in the Immune Microenvironment of the Hepatic Sinusoids for Treating Liver Diseases
Patten, D. A., Shepherd, E. L., Weston, C. J., & Shetty, S. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1678727 · Cited by 14
Roles of heterogenous hepatic macrophages in the progression of liver diseases
Lee, K., Kim, M., & Han, Y. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.4.022 · Cited by 13
“NKT and T cells to exacerbate liver inflammation (68).”
BackgroundNatural Killer T Cells in Various Mouse Models of Hepatitis
Guan, J., Wang, G., Yang, Q., Chen, C., Deng, J., Gu, X., & Zhu, H. (2021) · BioMed Research International · doi:10.1155/2021/1782765 · Cited by 11
CXCR6+CD4+ T cells promote mortality during Trypanosoma brucei infection
Liu, G., Abas, O. M., Strickland, A. B., Chen, Y., & Shi, M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009968 · Cited by 16
“The membranebound CXCL16 can be cleaved by the proteases, ADAM-10 or ADAM-17 [38], leading to the release of soluble form of CXCL16 which acts as a chemoattractant for CXCR6 cells [32,39].”
BackgroundHepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
Kholodenko, I. V., & Yarygin, K. N. (2023) · Biomedicines · doi:10.3390/biomedicines11113056 · Cited by 16
Role of Innate Immunity in Pediatric Post-transplant Idiopathic Liver Fibrosis
Wu, Y. H., Huang, M., Sun, H., Zhou, X., Zhou, R., Gu, G., & Xia, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02111 · Cited by 11
“Meanwhile, NKT cells can activate pro-inflammatory signals in Kuppfer cells (58).”
BackgroundEndo‐Umeda, K., Nakashima, H., Uno, S., Toyoshima, S., Umeda, N., Komine‐Aizawa, S., Seki, S., & Makishima, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-02062-z · Cited by 11
Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases
Handa, P., & Kowdley, K. V. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30918-4 · Cited by 10
A historical perspective of Kupffer cells in the context of infection
Graham, C. T., Gordon, S., & Kubes, P. (2024) · Cell and Tissue Research · doi:10.1007/s00441-024-03924-4 · Cited by 12
“…including CCL2 for monocyte infiltration, CCL5 responsible for recruiting various immune cells in different inflammatory contexts (Ju and Tacke 2016), and CXCL16, which may contribute to the recruitment of iNKT cells facilitated by endothelial cells (Geissmann et al. 2005; Wehr et al. 2013).”
Selvaraj, S., Oh, J., Yoon, S., & Borlak, J. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021445 · Cited by 9
“Moreover, we observed significant expression of the chemokine CXCL16 to about 60% of the controls, and this chemokine plays a role in the recruitment of natural killer (NK) T cells and is crucial in the initiation and progression of hepatic inflammation and fibrosis [93].”
BackgroundNoda, H., Suzuki, J., Matsuoka, Y., Matsumoto, A., Kuwahara, M., Kamei, Y., Takada, Y., & Yamashita, M. (2023) · Cancer Science · doi:10.1111/cas.15814 · Cited by 9
Dynamic Multiplex Tissue Imaging in Inflammation Research
Uderhardt, S., Neag, G., & Germain, R. N. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-070323-124158 · Cited by 10
Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus–Related Acute Liver Failure
Ajmera, V. H., Huang, H., Dao, D. Y., Feld, J. J., Lau, D., Patel, K., Rule, J. A., Daly, M. J., Lee, W. M., & Chung, R. T. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.09.018 · Cited by 9
The Roles of CXCL16 and CXCR6 in Liver Inflammation and Fibrosis
Wehr, A., & Tacke, F. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0090-2 · Cited by 8
Self-citationSpatial organization of tissue-resident memory T cells
Burn, T. N., & Mackay, L. K. (2026) · Immunity · doi:10.1016/j.immuni.2026.03.009 · Cited by 14
Update on the role of Chemokines and Chemokine Receptors in Liver Fibrosis
Li, H. (2023) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-4660 · Cited by 10
Papadopoulos, G., Giannousi, E., Avdi, A. P., Velliou, R.-I., Nikolakopoulou, P., & Chatzigeorgiou, A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1343806 · Cited by 8
Hepatic CXCL16 is increased in gallstone accompanied with liver injury
Zhang, S., Zhang, W., Shi, L., Xie, A., Shao, Y., Ye, Y., Pan, X., Lin, Z., Li, X., & Zhang, Y. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12788 · Cited by 8
Invariant natural killer T cells: Not to be ignored in liver disease
Gan, J., Mao, X. R., Zheng, S. J., & Li, J. F. (2021) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12968 · Cited by 10
“CXCR6-deficient mice were protected from liver fibrosis progression.(14) Furthermore, in vitro intravital two-photon microscopy imaging and chemotaxis study has revealed that CXCR6 specifically”
Background
Metadata
- Authors
- Wehr, A., Baeck, C., Heymann, F., Niemietz, P. M., Hammerich, L., Martin, C., Zimmermann, H. W., Pack, O., Gassler, N., Hittatiya, K., Ludwig, A., Luedde, T., Trautwein, C., & Tacke, F.
- Affiliations
- Universitätsklinikum Aachen (DE)
- University of Bonn (DE)
- Corresponding author
- Wehr, Alexander
- Baeck, Christer
- Heymann, Felix
- Hammerich, Linda
- Luedde, Tom
- Trautwein, Christian
- Tacke, Frank
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05
- Volume
- 190
- Issue
- 10
- Pages
- 5226-5236
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2149878896
- Cited by
- 268
- References
- 43
- Citations by year
- 2026: 8 · 2025: 21 · 2024: 20 · 2023: 28 · 2022: 31 · 2021: 32 · 2020: 20 · 2019: 18 · 2018: 20 · 2017: 18 · 2016: 9 · 2015: 20 · 2014: 19 · 2013: 4
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- CXCR6, CXCL16, NKT cells, liver fibrosis, liver inflammation, chemokine receptors, macrophage infiltration, interferon-gamma, IL-4, TNF-α, steatohepatitis, chronic liver injury
- MeSH terms
- Chemokine CXCL16, Receptors, CXCR6, Animals, Cell Movement, Cells, Cultured, Fatty Liver, Humans, Inflammation, Interferon-gamma, Liver, Liver Cirrhosis, Liver Diseases, Macrophages, Mice, Inbred C57BL, CD4-Positive T-Lymphocytes, Interleukin-4, Up-Regulation, Mice, Knockout, Adoptive Transfer, Hepatocytes, Mice, Receptors, CXCR, Chemokine CXCL6, Natural Killer T-Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.